{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:01:50Z","timestamp":1790517710548,"version":"4.1.0"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Data about SARS-CoV-2 vaccines efficacy in renal transplant recipients (RTR) are lacking.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>To reveal predictors for humoral response to BNT162b2 vaccine among RTR, patients were divided into positive (N = 42) and negative (N = 78) response groups based on receptor-binding domain (RBD) immunoglobulin G (IgG) \u22651.1 and neutralizing antibodies (NA) \u226516 dilution versus RBD IgG &lt;1.1 or NA &lt;16, respectively. NA were detected using a SARS-CoV-2 pseudo-virus.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>NA were detected in only 42 of 120 (35%) of RTR versus 197 of 202 (97.5%) immunocompetent controls (<jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001). NA geometric mean titers in RTR were significantly lower versus the control group {83.7 (95% confidence interval [CI], 50.5-138.8) versus 482 (95% CI, 411-566), <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001}. In a multivariable analysis, mycophenolic acid (MPA) dose and hemoglobin level were found to be independent predictors for antibody response in RTR. A positive response rate of 27% versus 63% was observed in patients on and off MPA, respectively. An increase in MPA dose by 1\u2009mg\/kg weight reduced the odds for a positive response by 17% (odds ratio = 0.83; 95% CI, 0.75-0.92; <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001). Geometric mean titers for RBD IgG were significantly reduced as MPA daily dose increased. Hemoglobin blood level &lt;13\u2009g\/dL reduced the antibody response by 63% (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.04). Pain at the injection site after the second vaccine dose was significantly higher in the responders versus nonresponders (20.5% versus 5.5%, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.01).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>Only 35% of RTR develop NA to the BNT162b2 mRNA vaccine. MPA is a major suppressor of antibody response in RTR.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000003889","type":"journal-article","created":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T20:03:25Z","timestamp":1626293005000},"page":"e234-e243","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":44,"title":["Humoral Response of Renal Transplant Recipients to the BNT162b2 SARS-CoV-2 mRNA Vaccine Using Both RBD IgG and Neutralizing Antibodies"],"prefix":"10.1097","volume":"105","author":[{"given":"Tammy","family":"Hod","sequence":"first","affiliation":[{"name":"Renal Transplant Center, Sheba Medical Center, Tel HaShomer, Israel."},{"name":"Nephrology Department, Sheba Medical Center, Tel HaShomer, Israel."},{"name":"Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aharon","family":"Ben-David","sequence":"additional","affiliation":[{"name":"Renal Transplant Center, Sheba Medical Center, Tel HaShomer, Israel."},{"name":"Nephrology Department, Sheba Medical Center, Tel HaShomer, Israel."},{"name":"Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liraz","family":"Olmer","sequence":"additional","affiliation":[{"name":"Bio-statistical and Bio-mathematical Unit, The Gertner Institute of Epidemiology and Health Policy Research, Sheba Medical Center, Tel HaShomer, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itzchak","family":"Levy","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel."},{"name":"The Infectious Diseases Unit, Sheba Medical Center, Tel HaShomer, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronen","family":"Ghinea","sequence":"additional","affiliation":[{"name":"Renal Transplant Center, Sheba Medical Center, Tel HaShomer, Israel."},{"name":"Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eytan","family":"Mor","sequence":"additional","affiliation":[{"name":"Renal Transplant Center, Sheba Medical Center, Tel HaShomer, Israel."},{"name":"Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaniv","family":"Lustig","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel."},{"name":"Central Virology Laboratory, Ministry of Health and Sheba Medical Center, Tel HaShomer, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galia","family":"Rahav","sequence":"additional","affiliation":[{"name":"Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel."},{"name":"The Infectious Diseases Unit, Sheba Medical Center, Tel HaShomer, Israel."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,7,6]]},"reference":[{"key":"R1-20250607","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1111\/ajt.16185","article-title":"COVID-19 and kidney transplantation: results from the TANGO International Transplant Consortium.","volume":"20","author":"Cravedi","year":"2020","journal-title":"Am J Transplant"},{"key":"R2-20250607","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/S0140-6736(20)31189-2","article-title":"Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study.","volume":"395","author":"Cummings","year":"2020","journal-title":"Lancet"},{"key":"R3-20250607","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1111\/ajt.16188","article-title":"Clinical characteristics and outcomes of COVID-19 in solid organ transplant recipients: a cohort study.","volume":"20","author":"Chaudhry","year":"2020","journal-title":"Am J Transplant"},{"key":"R4-20250607","doi-asserted-by":"crossref","first-page":"e13407","DOI":"10.1111\/tid.13407","article-title":"COVID-19 in solid organ transplant recipients: dynamics of disease progression and inflammatory markers in ICU and non-ICU admitted patients.","volume":"22","author":"Roberts","year":"2020","journal-title":"Transpl Infect Dis"},{"key":"R5-20250607","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/TP.0000000000003447","article-title":"COVID-19 outcomes among solid organ transplant recipients: a case-control study.","volume":"105","author":"Sharma","year":"2021","journal-title":"Transplantation"},{"key":"R6-20250607","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1111\/ajt.16280","article-title":"Outcomes of critically ill solid organ transplant patients with COVID-19 in the United States.","volume":"20","author":"Molnar","year":"2020","journal-title":"Am J Transplant"},{"key":"R7-20250607","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY.","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"R8-20250607","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1001\/jama.2020.5394","article-title":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy.","volume":"323","author":"Grasselli","year":"2020","journal-title":"JAMA"},{"key":"R9-20250607","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2215\/CJN.00700117","article-title":"Donor-Specific antibodies in kidney transplant recipients.","volume":"13","author":"Zhang","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"R10-20250607","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1111\/ajt.16541","article-title":"Prevalence and predictors of SARS-CoV-2 antibodies among solid organ transplant recipients with confirmed infection.","volume":"21","author":"Burack","year":"2021","journal-title":"Am J Transplant"},{"key":"R12-20250607","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine.","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"R13-20250607","doi-asserted-by":"crossref","first-page":"100651","DOI":"10.1016\/j.eclinm.2020.100651","article-title":"Multi-center nationwide comparison of seven serology assays reveals a SARS-CoV-2 non-responding seronegative subpopulation.","volume":"29","author":"Oved","year":"2020","journal-title":"EClinicalMedicine"},{"key":"R14-20250607","doi-asserted-by":"crossref","first-page":"e0241164","DOI":"10.1371\/journal.pone.0241164","article-title":"Testing IgG antibodies against the RBD of SARS-CoV-2 is sufficient and necessary for COVID-19 diagnosis.","volume":"15","author":"Indenbaum","year":"2020","journal-title":"PLoS One"},{"key":"R15-20250607","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/S0140-6736(21)00790-X","article-title":"COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study.","volume":"397","author":"Hall","year":"2021","journal-title":"Lancet"},{"key":"R16-20250607","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","article-title":"An mRNA vaccine against SARS-CoV-2\u2014Preliminary Report.","volume":"383","author":"Jackson","year":"2020","journal-title":"N Engl J Med"},{"key":"R17-20250607","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1056\/NEJMoa2027906","article-title":"Safety and immunogenicity of two RNA-based COVID-19 Vaccine candidates.","volume":"383","author":"Walsh","year":"2020","journal-title":"N Engl J Med"},{"key":"R18-20250607","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1001\/jama.2021.4385","article-title":"Immunogenicity of a single dose of SARS-CoV-2 messenger RNA vaccine in solid organ transplant recipients.","volume":"325","author":"Boyarsky","year":"2021","journal-title":"JAMA"},{"key":"R19-20250607","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1016\/j.kint.2021.03.014","article-title":"Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients.","volume":"99","author":"Benotmane","year":"2021","journal-title":"Kidney Int"},{"key":"R20-20250607","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1097\/TP.0000000000003784","article-title":"Poor anti-SARS-CoV-2 humoral and T-cell responses after 2 injections of mRNA vaccine in kidney transplant recipients treated with belatacept.","volume":"105","author":"Chavarot","year":"2021","journal-title":"Transplantation"},{"key":"R21-20250607","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1111\/ajt.16615","article-title":"Reduced humoral response to mRNA SARS-Cov-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus.","volume":"21","author":"Grupper","year":"2021","journal-title":"Am J Transplant"},{"key":"R22-20250607","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1111\/ajt.15296","article-title":"Humoral response to natural influenza infection in solid organ transplant recipients.","volume":"19","author":"Hirzel","year":"2019","journal-title":"Am J Transplant"},{"key":"R23-20250607","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1093\/cid\/cix1082","article-title":"A double-blind, randomized trial of high-dose vs standard-dose influenza vaccine in adult solid-organ transplant recipients.","volume":"66","author":"Natori","year":"2018","journal-title":"Clin Infect Dis"},{"key":"R24-20250607","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1086\/374784","article-title":"Randomized, double-blind, controlled trial of pneumococcal vaccination in renal transplant recipients.","volume":"187","author":"Kumar","year":"2003","journal-title":"J Infect Dis"},{"key":"R25-20250607","first-page":"235","article-title":"Hepatitis B vaccination results in 140 liver transplant recipients.","volume":"44","author":"Loinaz","year":"1997","journal-title":"Hepatogastroenterology"},{"key":"R26-20250607","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41598-020-80052-3","article-title":"A randomized controlled trial of comparative effectiveness between the 2 dose and 3 dose regimens of hepatitis A vaccine in kidney transplant recipients.","volume":"11","author":"Prasoppokakorn","year":"2021","journal-title":"Sci Rep"},{"key":"R27-20250607","first-page":"553","article-title":"Influenza vaccination on renal transplant patients is safe and serologically effective.","volume":"31","author":"Grekas","year":"1993","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"R28-20250607","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1399-0012.1996.tb00744.x","article-title":"Effective immunization against influenza in pediatric renal transplant recipients.","volume":"10","author":"Edvardsson","year":"1996","journal-title":"Clin Transplant"},{"key":"R29-20250607","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/clinids\/22.2.295","article-title":"The immunogenicity of influenza virus vaccine in solid organ transplant recipients.","volume":"22","author":"Blumberg","year":"1996","journal-title":"Clin Infect Dis"},{"key":"R30-20250607","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00007890-198610000-00009","article-title":"Impairment of the immune response to influenza vaccination in renal transplant recipients by cyclosporine, but not azathioprine.","volume":"42","author":"Versluis","year":"1986","journal-title":"Transplantation"},{"key":"R31-20250607","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/ndt\/13.1.160","article-title":"Suppression of the humoral immune response by mycophenolate mofetil.","volume":"13","author":"Smith","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"R32-20250607","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/00007890-200002150-00023","article-title":"Influenza virus immunization effectivity in kidney transplant patients subjected to two different triple-drug therapy immunosuppression protocols: mycophenolate versus azathioprine.","volume":"69","author":"Sanchez-Fructuoso","year":"2000","journal-title":"Transplantation"},{"key":"R33-20250607","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1086\/315125","article-title":"Immunogenicity and safety of hepatitis A vaccine in liver and renal transplant recipients.","volume":"180","author":"Stark","year":"1999","journal-title":"J Infect Dis"},{"key":"R34-20250607","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/tid.12217","article-title":"Efficacy and safety of hepatitis A vaccination in kidney transplant recipients.","volume":"16","author":"Jeon","year":"2014","journal-title":"Transpl Infect Dis"},{"key":"R35-20250607","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1046\/j.1523-1755.2002.00425.x","article-title":"Immune responsiveness in renal transplant recipients: mycophenolic acid severely depresses humoral immunity in vivo.","volume":"62","author":"Rentenaar","year":"2002","journal-title":"Kidney Int"},{"key":"R36-20250607","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0092-8674(00)81275-1","article-title":"Structure and mechanism of inosine monophosphate dehydrogenase in complex with the immunosuppressant mycophenolic acid.","volume":"85","author":"Sintchak","year":"1996","journal-title":"Cell"},{"key":"R37-20250607","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-3083.1991.tb03747.x","article-title":"Lymphocyte-selective antiproliferative and immunosuppressive effects of mycophenolic acid in mice.","volume":"33","author":"Eugui","year":"1991","journal-title":"Scand J Immunol"},{"key":"R38-20250607","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/00007890-199102000-00053","article-title":"Inhibition of both MLC and in vitro IgG memory response to tetanus toxoid by RS-61443.","volume":"51","author":"Burlingham","year":"1991","journal-title":"Transplantation"},{"key":"R39-20250607","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1097\/00007890-199560120-00001","article-title":"Reduced human IgG anti-ATGAM antibody formation in renal transplant recipients receiving mycophenolate mofetil.","volume":"60","author":"Kimball","year":"1995","journal-title":"Transplantation"},{"key":"R40-20250607","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1097\/TP.0000000000003824","article-title":"Immunogenicity and reactogenicity after SARS-CoV-2 mRNA vaccination in kidney transplant recipients taking belatacept.","volume":"105","author":"Ou","year":"2021","journal-title":"Transplantation"},{"key":"R41-20250607","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1111\/ajt.16701","article-title":"Cellular and humoral response after mRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients.","volume":"21","author":"Cucchiari","year":"2021","journal-title":"Am J Transplant"},{"key":"R42-20250607","doi-asserted-by":"crossref","first-page":"e150175","DOI":"10.1172\/JCI150175","article-title":"Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients.","volume":"131","author":"Sattler","year":"2021","journal-title":"J Clin Invest"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003889","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T16:14:33Z","timestamp":1749312873000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,6]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000003889","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,6]]}}}